Exact(1)
We thank all the members of the Hematological Malignancy Unit at the Venetian Institute of Molecular Medicine (VIMM).
Similar(59)
Since RIC transplantation depends on "allogeneic effect" to eliminate malignancy, each UCB unit represents an intact immune system with potential donor-recipient and donor-donor interactions that may render additional benefits of two-unit infusion, including enhanced graft vs. malignancy effects.
malignancy effect of 2-unit UCB infusion as reported in prior retrospective studies.
Several retrospective series have observed low relapse rates in hematologic malignancy patients with two-unit compared to single UCB graft infusion.
All consecutive patients with hematological malignancies admitted to this unit between 2000 and 2006, and who were diagnosed with either severe sepsis or septic shock, were considered for analysis.
Most patients had malignancy, but 7 intensive care unit hospitalizations also were recorded.
Introduction Patients with hematologic malignancies (HM) requiring intensive care unit (ICU) admission are assumed to have a poor prognosis.
We performed a retrospective analysis of a prospectively collected database of patients with hematological malignancies who required intensive care unit (ICU) admission in 2010 2011.
These centres were either oncology referral centres (i.e., tertiary centres for the treatment of women with gynaecological malignancy) or general hospitals and units with a special interest in gynaecological ultrasound.
Introduction Neurological failure in patients with hematological malignancy admitted to the intensive care unit has received little attention.
P232 Is diabetes mellitus a risk factor for intensive care unit-acquired infections in intensive care unit patients with hematologic malignancies?
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com